Testing Status of Tricombination ABC:DTG:3TC 18001
CASRN: TRICOMBOHIV2
Synonyms/Common Names
- Tri-Combo Therapy (ABC/DTG/3TC)
- Tri-combo therapy (ABC/DTG/3TC) (AIDS)
Secondary:
- 134678-17-4 - 3TC (AIDS initiative)
Short-Term Toxicity
- 3 months Subchronic (Gavage)
(C18001)
On Test
- Cardiovascular assessments - Female F0 Rats & Male and Female F1 Rats
- Rats: Hsd:Sprague Dawley SD
- Dose: 0, 150:12.5:75, 300:25:150 (ABC:DTG:3TC) mg/kg/day.
Modified One-Generation
- 8 weeks Dose Range Finding (Gavage)
(MOG18001)
Data in Review
- Rats: Hsd:Sprague Dawley SD
- Dose: ABC:DTG:3TC (12:1:6) are 0:0:0, 50:4.2:25, 100:8.3:50, 250:20.8:125, 400:33.3:200 mg/kg/day.
- 3 months Subchronic (Gavage)
(MOG18001B)
Data in Review
- Perinatal Subchronic Study
- Rats: Hsd:Sprague Dawley SD
- Dose: ABC:DTG:3TC (12:1:6) are 0:0:0, 50:4.2:25, 150:12.5:75, or 300:25:150 mg/kg/day.
- GD 18 and PND 4 Maternal Transfer (Gavage)
(MOG18001C)
Data in Review
- Biological Sampling
- Rats: Hsd:Sprague Dawley SD
- 18 months Neurotoxicology Assessment (Gavage)
(MOG18001D)
On Test
- Neurobehavior study of TRICOMBOHIV2 in Harlan Sprague Dawley Rats
- Male and Female Rats: Hsd:Sprague Dawley SD
- Dose: ABC:DTG:3TC (12:1:6) are 0:0:0, 50:4.2:25, 150:12.5:75, or 300:25:150 mg/kg/day.
Genetic Toxicology
- 27 days (dams) Micronucleus (Gavage)
(G18001C)
Completed
- Rats: Harlan Sprague-Dawley
- 27 days (pups) Micronucleus (Transplacental)
(G18001D)
Completed
- Rats: Harlan Sprague-Dawley
- 27 days (dams) Micronucleus (Gavage)
(G18001E)
On Test
- Rats: Harlan Sprague-Dawley
- 27 days (pups) Micronucleus (Transplacental)
(G18001H)
On Test
- Rats: Hsd:Sprague Dawley SD
- 27 days (dams) Pig-a gene mutation (Gavage)
(G18001F)
On Test
- Rats: Harlan Sprague-Dawley
- 27 days (pups) Pig-a gene mutation (Transplacental)
(G18001G)
On Test
- Rats: Harlan Sprague-Dawley